{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:51:23Z","timestamp":1782996683304,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Neurological Institute C. Besta IRCCS Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00415-016-8072-9","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T13:06:05Z","timestamp":1456837565000},"page":"871-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Validation of the MG-DIS: a disability assessment for myasthenia gravis"],"prefix":"10.1007","volume":"263","author":[{"given":"Alberto","family":"Raggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Schiavolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Brenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"key":"8072_CR1","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present, and future. J Clin Invest 116:2843\u20132854","journal-title":"J Clin Invest"},{"key":"8072_CR2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1254.054","volume":"998","author":"R Mantegazza","year":"2003","unstructured":"Mantegazza R, Baggi F, Antozzi C, Confalonieri P, Morandi L, Bernasconi P, Andreetta F, Simoncini O, Campanella A, Beghi E, Cornelio F (2003) Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann NY Acad Sci 998:413\u2013423","journal-title":"Ann NY Acad Sci"},{"key":"8072_CR3","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","volume":"357","author":"A Vincent","year":"2001","unstructured":"Vincent A, Palace J, Hilton-Jones D (2001) Myasthenia gravis. Lancet 357:2122\u20132128","journal-title":"Lancet"},{"key":"8072_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mus.21713","volume":"42","author":"TM Burns","year":"2010","unstructured":"Burns TM (2010) History of outcome measures for myasthenia gravis. Muscle Nerve 42:5\u201313","journal-title":"Muscle Nerve"},{"key":"8072_CR5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.23330","volume":"45","author":"M Benatar","year":"2012","unstructured":"Benatar M, Sanders DB, Burns TM, Cutter GR, Guptill JT, Baggi F, Kaminski HJ, Mantegazza R, Meriggioli MN, Quan J, Wolfe GI, Task Force on MG Study Design of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America (2012) Recommendations for myasthenia gravis clinical trials. Muscle Nerve 45:909\u2013917","journal-title":"Muscle Nerve"},{"key":"8072_CR6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4135\/9781848608344.n11","volume-title":"The advanced handbook of methods in evidence based healthcare","author":"R Fitzpatrick","year":"2001","unstructured":"Fitzpatrick R, Davey C, Buxton M, Jones DR (2001) Criteria for assessing patient based outcome measures for use in clinical trials. In: Stevens A, Abrams K, Brazier J, Fitzpatrick R, Lilford R (eds) The advanced handbook of methods in evidence based healthcare. Sage, London, pp 181\u2013194"},{"key":"8072_CR7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1136\/bmj.317.7167.1191","volume":"317","author":"C Sanders","year":"1998","unstructured":"Sanders C, Egger M, Donovan J, Tallon D, Frankel S (1998) Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ 317:1191\u20131194","journal-title":"BMJ"},{"key":"8072_CR8","first-page":"1","volume":"2","author":"R Fitzpatrick","year":"1998","unstructured":"Fitzpatrick R, Davey C, Buxton MJ, Jones DR (1998) Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 2:1\u201374","journal-title":"Health Technol Assess"},{"key":"8072_CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00415-009-5279-z","volume":"257","author":"M Leonardi","year":"2010","unstructured":"Leonardi M, Raggi A, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R (2010) The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study. J Neurol 257:98\u2013102","journal-title":"J Neurol"},{"key":"8072_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10072-009-0167-y","volume":"31","author":"A Raggi","year":"2010","unstructured":"Raggi A, Leonardi M, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R (2010) Concordance between severity of disease, disability and health-related quality of life in myasthenia gravis. Neurol Sci 31:41\u201345","journal-title":"Neurol Sci"},{"key":"8072_CR11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/mus.24214","volume":"50","author":"ME Farrugia","year":"2014","unstructured":"Farrugia ME, Carmichael C, Cupka BJ, Warder J, Brennan KM, Burns TM (2014) The modified rankin scale to assess disability in myasthenia gravis: comparing with other tools. Muscle Nerve 50:501\u2013507","journal-title":"Muscle Nerve"},{"key":"8072_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/CND.0b013e31824619d5","volume":"13","author":"C Barnett","year":"2012","unstructured":"Barnett C, Katzberg H, Nabavi M, Bril V (2012) The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers. J Clin Neuromuscul Dis 13:201\u2013205","journal-title":"J Clin Neuromuscul Dis"},{"key":"8072_CR13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mus.21016","volume":"38","author":"LL Mullins","year":"2008","unstructured":"Mullins LL, Carpentier MY, Paul RH, Sanders DB, Muscle Study Group (2008) Disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve 38:947\u2013956","journal-title":"Muscle Nerve"},{"key":"8072_CR14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mus.21053","volume":"38","author":"TM Burns","year":"2008","unstructured":"Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group (2008) Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis. Muscle Nerve 38:957\u2013963","journal-title":"Muscle Nerve"},{"key":"8072_CR15","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00415-011-5913-4","volume":"258","author":"YT Chen","year":"2011","unstructured":"Chen YT, Chang Y, Chiu HC, Yeh JH (2011) Psychosocial aspects in myasthenic patients treated by plasmapheresis. J Neurol 258:1240\u20131246","journal-title":"J Neurol"},{"key":"8072_CR16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3109\/09638288.2013.804591","volume":"36","author":"A Raggi","year":"2014","unstructured":"Raggi A, Schiavolin S, Leonardi M, Antozzi C, Baggi F, Maggi L, Mantegazza R (2014) Development of the MG-DIS: an ICF-based disability assessment instrument for myasthenia gravis. Disabil Rehabil 36:546\u2013555","journal-title":"Disabil Rehabil"},{"key":"8072_CR17","volume-title":"International classification of functioning, disability and health (ICF)","author":"World Health Organization","year":"2001","unstructured":"World Health Organization (2001) International classification of functioning, disability and health (ICF). WHO, Geneva"},{"key":"8072_CR18","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3109\/09638280902893634","volume":"31","author":"M Leonardi","year":"2009","unstructured":"Leonardi M, Raggi A, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R (2009) Identification of international classification of functioning, disability and health relevant categories to describe functioning and disability of patients with myasthenia gravis. Disabil Rehabil 31:2041\u20132046","journal-title":"Disabil Rehabil"},{"key":"8072_CR19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00314245","volume":"235","author":"R Mantegazza","year":"1988","unstructured":"Mantegazza R, Antozzi C, Peluchetti D, Sghirlanzoni A, Cornelio F (1988) Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J Neurol 235:449\u2013453","journal-title":"J Neurol"},{"key":"8072_CR20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mus.24911","volume":"53","author":"C Antozzi","year":"2016","unstructured":"Antozzi C, Brenna G, Baggi F, Camera G, Maggi L, Rezzani C, Montomoli C, Mantegazza R (2016) Validation of the besta neurological institute rating scale for myasthenia gravis. Muscle Nerve 53:32\u201337. doi: 10.1002\/mus.24911","journal-title":"Muscle Nerve"},{"key":"8072_CR21","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e3181dc1b1e","volume":"74","author":"TM Burns","year":"2010","unstructured":"Burns TM, Conaway M, Sanders DB, MG Composite and MG-QOL15 Study Group (2010) The MG composite: a valid and reliable tool for myasthenia gravis. Neurology 74:1434\u20131440","journal-title":"Neurology"},{"key":"8072_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1477-7525-8-51","volume":"8","author":"O Garin","year":"2010","unstructured":"Garin O, Ayuso-Mateos JL, Almansa J, Nieto M, Chatterji S, Vilagut G, Alonso J, Cieza A, Svestkova O, Burger H, Racca V, Francescutti C, Vieta E, Kostanjsek N, Raggi A, Leonardi M, Ferrer M, MHADIE consortium (2010) Validation of the \u201cWorld Health Organization disability assessment schedule, WHODAS-2\u201d in patients with chronic diseases. Health Qual Life Outcomes 8:51","journal-title":"Health Qual Life Outcomes"},{"key":"8072_CR23","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","volume":"25","author":"JE Ware","year":"2000","unstructured":"Ware JE (2000) SF-36 health survey update. Spine 25:3130\u20133139","journal-title":"Spine"},{"key":"8072_CR24","volume-title":"Discovering statistics using SPSS","author":"A Field","year":"2009","unstructured":"Field A (2009) Discovering statistics using SPSS, 3rd edn. Sage, London","edition":"3"},{"key":"8072_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10705519909540118","volume":"6","author":"L Hu","year":"1994","unstructured":"Hu L, Bentler PM (1994) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model 6:1\u201355","journal-title":"Struct Equ Model"},{"key":"8072_CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02291575","volume":"39","author":"HF Kaiser","year":"1974","unstructured":"Kaiser HF (1974) An index of factor simplicity. Psychometrika 39:31\u201336","journal-title":"Psychometrika"},{"key":"8072_CR27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.314.7080.572","volume":"314","author":"JM Bland","year":"1997","unstructured":"Bland JM, Altman DG (1997) Cronbach\u2019s alpha. BMJ 314:572","journal-title":"BMJ"},{"key":"8072_CR28","volume-title":"Psychometric theory","author":"JC Nunnally","year":"1994","unstructured":"Nunnally JC, Bernstein I (1994) Psychometric theory, 3rd edn. McGraw-Hill, New York","edition":"3"},{"key":"8072_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323","journal-title":"Neurology"},{"key":"8072_CR30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1212\/WNL.0b013e31827b907b","volume":"80","author":"F Baggi","year":"2013","unstructured":"Baggi F, Andreetta F, Maggi L, Confalonieri P, Morandi L, Salerno F, Bernasconi P, Montomoli C, Barberis M, Mantegazza R, Antozzi C (2013) Complete stable remission and autoantibody specificity in myasthenia gravis. Neurology 80:188\u2013195","journal-title":"Neurology"},{"key":"8072_CR31","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/ene.12703","volume":"22","author":"A Ramos-Fransi","year":"2015","unstructured":"Ramos-Fransi A, Rojas-Garc\u00eda R, Segovia S, M\u00e1rquez-Infante C, Pardo J, Coll-Cant\u00ed J, Jeric\u00f3 I, Illa I, Myasthenia NMD-ES Study Group (2015) Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry. Eur J Neurol 22:1056\u20131061","journal-title":"Eur J Neurol"},{"key":"8072_CR32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","volume":"37","author":"D Grob","year":"2008","unstructured":"Grob D, Brunner N, Namba T, Pagala M (2008) Lifetime course of myasthenia gravis. Muscle Nerve 37:141\u2013149","journal-title":"Muscle Nerve"},{"key":"8072_CR33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s100720200027","volume":"23","author":"L Padua","year":"2002","unstructured":"Padua L, Evoli A, Aprile I, Caliandro P, Batocchi AP, Punzi C, Mazza S, Padua R, Tonali P (2002) Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire. Neurol Sci 23:59\u201368","journal-title":"Neurol Sci"},{"key":"8072_CR34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mus.22140","volume":"44","author":"S Muppidi","year":"2011","unstructured":"Muppidi S, Wolfe GI, Conaway M, Burns TM, MG Composite and MG-QOL15 Study Group (2011) MG-ADL: still a relevant outcome measure. Muscle Nerve 44:727\u2013731","journal-title":"Muscle Nerve"},{"key":"8072_CR35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/01.cnd.0000202223.39994.c0","volume":"7","author":"KR Scott","year":"2006","unstructured":"Scott KR, Kothari MJ (2006) Self-reported pain affects quality of life in myasthenia gravis. J Clin Neuromuscul Dis 7:110\u2013114","journal-title":"J Clin Neuromuscul Dis"},{"key":"8072_CR36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1749-8090-7-98","volume":"7","author":"C Su","year":"2012","unstructured":"Su C, Su Y, Chou CW, Liu W, Zou J, Luo H, Chen Z (2012) Intravenous flurbiprofen for post-thymectomy pain relief in patients with myasthenia gravis. J Cardiothorac Surg 7:98","journal-title":"J Cardiothorac Surg"},{"key":"8072_CR37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1399-6576.1997.tb04743.x","volume":"41","author":"E Nilsson","year":"1997","unstructured":"Nilsson E, Perttunen K, Kalso E (1997) Intrathecal morphine for post-sternotomy pain in patients with myasthenia gravis: effects on respiratory function. Acta Anaesthesiol Scand 41:549\u2013556","journal-title":"Acta Anaesthesiol Scand"},{"key":"8072_CR38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpainsymman.2007.02.041","volume":"35","author":"C Guy-Coichard","year":"2008","unstructured":"Guy-Coichard C, Nguyen DT, Delorme T, Boureau F (2008) Pain in hereditary neuromuscular disorders and myasthenia gravis: a national survey of frequency, characteristics, and impact. J Pain Symptom Manag 35:40\u201350","journal-title":"J Pain Symptom Manag"},{"key":"8072_CR39","doi-asserted-by":"crossref","first-page":"e98089","DOI":"10.1371\/journal.pone.0098089","volume":"9","author":"C Barnett","year":"2014","unstructured":"Barnett C, Bril V, Kapral M, Kulkarni A, Davis AM (2014) A conceptual framework for evaluating impairments in myasthenia gravis. PLoS One 9:e98089","journal-title":"PLoS One"},{"key":"8072_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/CND.0000000000000034","volume":"15","author":"NJ Silvestri","year":"2014","unstructured":"Silvestri NJ, Wolfe GI (2014) Treatment-refractory myasthenia gravis. J Clin Neuromuscul Dis 15:167\u2013178","journal-title":"J Clin Neuromuscul Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8072-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8072-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8072-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:23:00Z","timestamp":1559071380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8072-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["8072"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8072-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,1]]}}}